Cellino
Your Cells, Your Cure
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- cellinobio.com
- Total Funding
- $121.0M
- Last Round
- $25.0M GrantSep 2024
About
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized regenerative medicines using AI-guided laser editing and automation. The company's platform enables autologous iPSC-derived cell therapies to scale from research to clinical and commercial production, targeting degenerative diseases with a 'Your Cells, Your Cure' approach.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account